Black Swan Sale

50% Off Elite

00
Days
00
Hours
00
Mins
00
Sec
Register Now!

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

Index- P/E- EPS (ttm)-0.01 Insider Own88.56% Shs Outstand494.49M Perf Week-8.64%
Market Cap5.70B Forward P/E- EPS next Y- Insider Trans0.00% Shs Float56.59M Perf Month-30.58%
Enterprise Value5.70B PEG- EPS next Q- Inst Own0.13% Short Float2.14% Perf Quarter-17.94%
Income-3.58M P/S- EPS this Y- Inst Trans-10.48% Short Ratio6.45 Perf Half Y-50.04%
Sales0.00M P/B1172.94 EPS next Y- ROA-50.50% Short Interest1.21M Perf YTD8769.23%
Book/sh0.01 P/C1163.56 EPS next 5Y- ROE-54.81% 52W High83.60 -86.21% Perf Year7319.81%
Cash/sh0.01 P/FCF- EPS past 3/5Y22.39% -33.47% ROIC-70.39% 52W Low0.09 12325.98% Perf 3Y1838.67%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility10.04% 8.56% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM17.24% Oper. Margin- ATR (14)1.14 Perf 10Y-
Dividend Ex-Date- Quick Ratio7.39 Sales Y/Y TTM- Profit Margin- RSI (14)35.08 Recom-
Dividend Gr. 3/5Y- - Current Ratio7.39 EPS Q/Q22.22% SMA20-11.29% Beta2.06 Target Price-
Payout- Debt/Eq0.11 Sales Q/Q- SMA50-24.17% Rel Volume0.82 Prev Close11.11
Employees10 LT Debt/Eq0.05 Earnings- SMA200-0.83% Avg Volume187.69K Price11.53
IPOJul 16, 2021 Option/ShortYes / Yes EPS/Sales Surpr.- - Trades Volume166,819 Change3.78%
Nov-24-25 09:05AM
Oct-22-25 05:47PM
Oct-01-25 01:39PM
Sep-04-25 01:01PM
Sep-03-25 03:51AM
03:51AM Loading…
Aug-04-25 03:51AM
Jul-31-25 11:31PM
Jul-17-25 03:51PM
Jul-08-25 02:26PM
Jul-07-25 10:34AM
Jul-01-25 03:51AM
Jun-30-25 04:03PM
Jun-27-25 12:05PM
05:18AM
Jun-20-25 03:06AM
12:43PM Loading…
Jun-17-25 12:43PM
12:25PM
Jun-16-25 04:30PM
11:00AM
Apr-30-25 06:01AM
Mar-22-25 11:00AM
Mar-21-25 06:35AM
Mar-17-25 07:28AM
Jul-23-24 04:02PM
Nov-15-23 04:31PM
Jul-31-23 08:15AM
Apr-03-23 07:25AM
Feb-21-23 06:36AM
Nov-21-22 06:49AM
Nov-15-22 07:55AM
06:55AM Loading…
Oct-25-22 06:55AM
Sep-14-22 06:55AM
Sep-12-22 09:15AM
Jun-20-22 05:27AM
May-24-22 05:46AM
May-18-22 08:05AM
06:14AM
May-16-22 08:56AM
Apr-14-22 10:03AM
Apr-07-22 06:09AM
Mar-01-22 08:30AM
Feb-17-22 11:40AM
Feb-16-22 08:42PM
Dec-13-21 08:35AM
Nov-22-21 08:15AM
08:00AM
Nov-02-21 04:00AM
Oct-19-21 11:44AM
Sep-10-21 06:18AM
02:42AM
Sep-02-21 08:00AM
Aug-20-21 08:00AM
Aug-05-21 08:00AM
Jul-20-21 04:05PM
Jul-16-21 11:43AM
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.